Agency Awarded for Most Innovative Campaign
COLUMBUS, OHIO, June 7, 2007 — Ignite Health, an inVentiv Health company (NASDAQ: VTIV), and a leading marketing agency that specializes in patient-centered medical advertising, was recognized for Most Innovative Campaign in the 2007 Pharmaceutical Advertising and Marketing Excellence (PhAME) Awards. PhAME honors the pharmaceutical industry's most creative, effective and responsible direct-to-consumer campaigns. The awards were presented on May 3 at the Solomon Guggenheim Museum in New York City.
Ignite won the Most Innovative Campaign for "Live With It," an animated Web series featuring reality-based storylines that follow the lives of fictional characters learning to deal with the fact that they are HIV-positive. The series, found at www.LiveWithIt.com, was developed by Incendia Health Studios, a division of Ignite that develops and distributes unbranded disease education content.
"Being recognized for our creative work is always a thrill — and this is especially true for the PhAME Awards because they honor not only the quality of the work, but also the effectiveness of the campaign," said Fabio Gratton, chief innovation officer for Ignite Health. "This series has had such a positive impact with the HIV-positive population. Since the series launched in late 2005, LiveWithIt.com has received more than 30,000 visitors and the episodes have been downloaded over 50,000 times — and the feedback from visitors and sponsors has been outstanding. Needless to say, we feel very gratified."
The PhAME Awards are given annually to consumer marketing campaigns that exemplify both outstanding creativity and achievement of identified business results.
About Ignite Health
Headquartered in Irvine, California, Ignite Health is a new breed of advertising agency with a fresh approach to healthcare marketing and communications. By complementing highly focused print strategies with a wide range of tailored electronic strategies — from online advertising and patient education to custom-engineered games and simulations — the company helps clients meet their objectives with unparalleled effectiveness and efficiency. For more information, visit www.ignitehealth.com.
About inVentiv Health
inVentiv Health (NASDAQ: VTIV) is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health currently works with over 200 unique pharmaceutical, biotech and life sciences clients, including all top 20 global pharmaceutical companies. For more information, visit www.inventivhealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by Ventiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.